Diabetes 50:1821-1827, 2001
© 2001 by the American Diabetes Association, Inc.
Alteration in Phosphorylation of P20 Is Associated With Insulin Resistance
Yu Wang1,
Aimin Xu1,
Jiming Ye2,
Edward W. Kraegen2,
Cynthia A. Tse1, and
Garth J.S. Cooper1,3
1 School of Biological Sciences, University of Auckland, Auckland, New Zealand
2 Garvan Institute of Medical Research, Sydney, Australia
3 Department of Medicine, School of Medicine, University of Auckland, Auckland, New Zealand
We have recently identified a small phosphoprotein, P20, as a common intracellular target for insulin and several of its antagonists, including amylin, epinephrine, and calcitonin gene-related peptide. These hormones elicit phosphorylation of P20 at its different sites, producing three phosphorylated isoforms: S1 with an isoelectric point (pI) value of 6.0, S2 with a pI value of 5.9, and S3 with a pI value of 5.6 (FEBS Letters 457:149152 and 462:2530, 1999). In the current study, we showed that P20 is one of the most abundant phosphoproteins in rat extensor digitorum longus (EDL) muscle. Insulin and amylin antagonize each others actions in the phosphorylation of this protein in rat EDL muscle. Insulin inhibits amylin-evoked phosphorylation of S2 and S3, whereas amylin decreases insulin-induced phosphorylation of S1. In rats made insulin resistant by dexamethasone treatment, levels of the phosphoisoforms S2 and S3, which were barely detectable in healthy rats in the absence of hormone stimulation, were significantly increased. Moreover, the ability of insulin to inhibit amylin-evoked phosphorylation of these two isoforms was greatly attenuated. These results suggested that alterations in the phosphorylation of P20 might be associated with insulin resistance and that P20 could serve as a useful marker to dissect the cellular mechanisms of this disease.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G.-C. Fan, X. Ren, J. Qian, Q. Yuan, P. Nicolaou, Y. Wang, W. K. Jones, G. Chu, and E. G. Kranias
Novel Cardioprotective Role of a Small Heat-Shock Protein, Hsp20, Against Ischemia/Reperfusion Injury
Circulation,
April 12, 2005;
111(14):
1792 - 1799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-C. Fan, G. Chu, B. Mitton, Q. Song, Q. Yuan, and E. G. Kranias
Small Heat-Shock Protein Hsp20 Phosphorylation Inhibits {beta}-Agonist-Induced Cardiac Apoptosis
Circ. Res.,
June 11, 2004;
94(11):
1474 - 1482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chu, G. F. Egnaczyk, W. Zhao, S.-H. Jo, G.-C. Fan, J. E. Maggio, R.-P. Xiao, and E. G. Kranias
Phosphoproteome Analysis of Cardiomyocytes Subjected to {beta}-Adrenergic Stimulation: Identification and Characterization of a Cardiac Heat Shock Protein p20
Circ. Res.,
February 6, 2004;
94(2):
184 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, A. Xu, C. Knight, L. Y. Xu, and G. J. S. Cooper
Hydroxylation and Glycosylation of the Four Conserved Lysine Residues in the Collagenous Domain of Adiponectin. POTENTIAL ROLE IN THE MODULATION OF ITS INSULIN-SENSITIZING ACTIVITY
J. Biol. Chem.,
May 24, 2002;
277(22):
19521 - 19529.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|